Cromos Pharma recruits 473 patients (92% of total) into a breast cancer trial, all in under 7 months.
Cromos Pharma recruits 473 patients (92% of total) into a breast cancer trial, all in under 7 months. Budapest, Hungary. We are happy to announce that Cromos Pharma has just completed the recruitment of a large registration breast cancer trial. The trial is being conducted in 9 countries and is being performed in collaboration with an international academic group. Initially contracted with recruiting 200 patients across 4 countries, Cromos has exceeded everyone’s expectations
Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint
Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint PORTLAND, Ore., Dec. 11, 2017 (GLOBE NEWSWIRE) – Cromos™ Pharma, a premier regional contract research organization announced today that Stephanie Finnegan has been appointed as its Chief Operating Officer. Ms. Finnegan will join the company’s US office and will oversee its European and US operations. “We are very excited to see Ms. Finnegan joining our
Cromos™ Pharma shares its experience with clinical trials in Kazakhstan in Applied Clinical Trials
Cromos™ Pharma shares its experience with clinical trials in Kazakhstan in Applied Clinical Trials Cromos™ Pharma has published an article on Clinical trials in Kazakhstan in Applied Clinical Trials journal. The company has recently initiated 3 late stage trials and the article describes its experience with the emphasis on the regulatory approval process. Please follow this link to access the article.

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM